ENTRY       D09646                      Drug
NAME        Ocriplasmin (USAN/INN);
            Ocriplasmin (genetical recombination) (JAN);
            Jetrea (TN)
FORMULA     C1214H1890N338O348S14
EXACT_MASS  27219.6676
MOL_WEIGHT  27236.9622
REMARK      ATC code: S01XA22
EFFICACY    Cell adhesion molecule, Enzyme (proteolytic)
COMMENT     recombinant C-terminal fragment of human plasmin [EC:3.4.21.7]
            Treatment of symptomatic vitreomacular adhesion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01X OTHER OPHTHALMOLOGICALS
                S01XA Other ophthalmologicals
                 S01XA22 Ocriplasmin
                  D09646  Ocriplasmin (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09646
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09646
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09646
DBLINKS     CAS: 1048016-09-6
            PubChem: 124490386
///
